LOUISVILLE, Ky. (AP) -- Pharmacy management services company PharMerica Corp. said Friday that antitrust regulators cleared its proposed purchase of Chem Rx Corp.
PharMerica said a mandatory regulatory review period has expired. The company said in September that it would buy Chem Rx, a long-term care pharmacy, for $70.6 million.
Chem Rx filed for Chapter 11 bankruptcy protection in May and a bankruptcy court still needs to approve the sale before it can be competed.
In midday trading, PharMerica stock gave up 3 cents to $9.50.
No comments:
Post a Comment